Open access peer-reviewed chapter

Neoadjuvant Chemotherapy for Soft Tissue Sarcoma of the Extremity or Trunk, Gastrointestinal Stromal Tumors, and Retroperitoneal Sarcoma

By Lloyd Mack and Walley Temple

Submitted: March 5th 2011Reviewed: October 14th 2011Published: February 1st 2012

DOI: 10.5772/29198

Downloaded: 1676

© 2012 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Lloyd Mack and Walley Temple (February 1st 2012). Neoadjuvant Chemotherapy for Soft Tissue Sarcoma of the Extremity or Trunk, Gastrointestinal Stromal Tumors, and Retroperitoneal Sarcoma, Neoadjuvant Chemotherapy - Current Applications in Clinical Practice, Oliver F. Bathe, IntechOpen, DOI: 10.5772/29198. Available from:

chapter statistics

1676total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Effects of Neoadjuvant Chemotherapy in High-Grade Non-Metastatic Osteosarcoma of Extremities

By Milan Samardziski, Vesna Janevska, Beti Zafirova-Ivanovska, Violeta Vasilevska and Slavica Kraleva

Related Book

First chapter

Breast and Ovarian Cancer Treatment: Facing Forward Women's Health Care

By Alice Laschuk Herlinger, Klesia Pirola Madeira, Renata Dalmaschio Daltoé, Ian Victor Silva, Marco César Cunegundes Guimarães and Leticia Batista Azevedo Rangel

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

More About Us